The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial

BACKGROUND: Buprenorphine is usually administered to treat opioid use disorder and pain syndromes. This research presents the first study regarding the effectiveness of different singly administered high doses of buprenorphine (a partial opioid agonist (of μ-opioid receptors), a potent opioid antago...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Jamshid, Jahromi, Mina Sefidfard, Ehsaei, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114789/
https://www.ncbi.nlm.nih.gov/pubmed/30157924
http://dx.doi.org/10.1186/s13063-018-2843-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114789/
https://www.ncbi.nlm.nih.gov/pubmed/30157924
http://dx.doi.org/10.1186/s13063-018-2843-9

Ejemplares similares